PubMed:15385432 / 1549-1787 JSONTXT

{"project":"Glycan-Motif","denotations":[{"id":"T19","span":{"begin":80,"end":96},"obj":"https://glytoucan.org/Structures/Glycans/G71142DF"},{"id":"T20","span":{"begin":234,"end":237},"obj":"https://glytoucan.org/Structures/Glycans/G56516VH"},{"id":"T21","span":{"begin":234,"end":237},"obj":"https://glytoucan.org/Structures/Glycans/G91237TK"}],"text":"Treatment with L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP), glucosylceramide synthase inhibitor, decreased induction of not only CD11b expression but also cellular adherence by reduction of PMA-induced ganglioside GM3."}

{"project":"GlyCosmos6-Glycan-Motif-Image","denotations":[{"id":"T19","span":{"begin":80,"end":96},"obj":"Glycan_Motif"},{"id":"T20","span":{"begin":234,"end":237},"obj":"Glycan_Motif"}],"attributes":[{"id":"A19","pred":"image","subj":"T19","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G71142DF"},{"id":"A20","pred":"image","subj":"T20","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G91237TK"},{"id":"A21","pred":"image","subj":"T20","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G56516VH"}],"text":"Treatment with L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP), glucosylceramide synthase inhibitor, decreased induction of not only CD11b expression but also cellular adherence by reduction of PMA-induced ganglioside GM3."}

{"project":"sentences","denotations":[{"id":"TextSentencer_T9","span":{"begin":0,"end":238},"obj":"Sentence"},{"id":"T9","span":{"begin":0,"end":238},"obj":"Sentence"},{"id":"T9","span":{"begin":0,"end":238},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Treatment with L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP), glucosylceramide synthase inhibitor, decreased induction of not only CD11b expression but also cellular adherence by reduction of PMA-induced ganglioside GM3."}

{"project":"GlyCosmos6-Glycan-Motif-Structure","denotations":[{"id":"T19","span":{"begin":80,"end":96},"obj":"https://glytoucan.org/Structures/Glycans/G71142DF"},{"id":"T20","span":{"begin":234,"end":237},"obj":"https://glytoucan.org/Structures/Glycans/G56516VH"},{"id":"T21","span":{"begin":234,"end":237},"obj":"https://glytoucan.org/Structures/Glycans/G91237TK"}],"text":"Treatment with L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP), glucosylceramide synthase inhibitor, decreased induction of not only CD11b expression but also cellular adherence by reduction of PMA-induced ganglioside GM3."}

{"project":"mondo_disease","denotations":[{"id":"T14","span":{"begin":210,"end":213},"obj":"Disease"}],"attributes":[{"id":"A14","pred":"mondo_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/MONDO_0016692"},{"id":"A15","pred":"mondo_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/MONDO_0018687"}],"text":"Treatment with L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP), glucosylceramide synthase inhibitor, decreased induction of not only CD11b expression but also cellular adherence by reduction of PMA-induced ganglioside GM3."}

{"project":"uniprot-human","denotations":[{"id":"T38","span":{"begin":149,"end":154},"obj":"http://www.uniprot.org/uniprot/P11215"},{"id":"T41","span":{"begin":80,"end":105},"obj":"http://www.uniprot.org/uniprot/Q16739"}],"text":"Treatment with L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP), glucosylceramide synthase inhibitor, decreased induction of not only CD11b expression but also cellular adherence by reduction of PMA-induced ganglioside GM3."}

{"project":"uniprot-mouse","denotations":[{"id":"T27","span":{"begin":149,"end":154},"obj":"http://www.uniprot.org/uniprot/P05555"},{"id":"T30","span":{"begin":80,"end":105},"obj":"http://www.uniprot.org/uniprot/O88693"}],"text":"Treatment with L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP), glucosylceramide synthase inhibitor, decreased induction of not only CD11b expression but also cellular adherence by reduction of PMA-induced ganglioside GM3."}

{"project":"GO-BP","denotations":[{"id":"T50","span":{"begin":175,"end":183},"obj":"http://purl.obolibrary.org/obo/GO_0007349"}],"text":"Treatment with L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP), glucosylceramide synthase inhibitor, decreased induction of not only CD11b expression but also cellular adherence by reduction of PMA-induced ganglioside GM3."}

{"project":"Lectin","denotations":[{"id":"Lectin_T7","span":{"begin":210,"end":213},"obj":"https://acgg.asia/db/lfdb/LfDB0219"}],"text":"Treatment with L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP), glucosylceramide synthase inhibitor, decreased induction of not only CD11b expression but also cellular adherence by reduction of PMA-induced ganglioside GM3."}